Figure 3From: Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy Baseline (white) and 12 month (black) FACT-P Quality of Life questionnaire in 20 men with biochemical recurrent prostate cancer after previous therapy. (PWB, physical well being; SWB, social well being; EWB, emotional well being; FWB, functional well being; PCS, prostate cancer specific).Back to article page